medigraphic.com
Boletín Médico del Hospital Infantil de México

2010, Number 2

<< Back Next >>

Bol Med Hosp Infant Mex 2010; 67 (2)

Experience in the surgical closure of patent ductus arteriosus in the Neonatal Intensive Care Unit of a second-level hospital in Guadalajara, Jalisco, Mexico

Gallardo MAF, González SJM, Piña GMÁ, Medina AMÁ, Cabrera RH, Lozano Ruy-Sánchez A, Rivera CJF, Vázquez JH, González FF

Language: Spanish
References: 24
Page: 128-132
PDF size: 109.62 Kb.


ABSTRACT

Background: Patent ductus arteriosus (PDA) is the most common congenital cardiac defect affecting 80% of very low birth weight preterm newborns (‹1 000 g) and is considered an important public health issue. The aim was to demonstrate that it is possible to perform surgical closure of PDA on premature newborns in a second-level hospital.
Methods: We analyzed backgrounds and clinical evolution of 31 surgically treated patients with PDA. Criteria for surgical closure were 1) pharmacological closure failure, 2) pulmonary hypertension with left to right shunt, 3) echocardiogram with ductal diameter ›1.5 mm, and Qs/Qp ratio (›1.5:1. 4) at ›5 days of extrauterine life. All patients were operated using left posterolateral thoracotomy with extrapleural dissection and ductus closure with a 2-0 double silk ligature.
Results: We studied 31 patients: 19 males and 12 females. Age range was between 30 and 35 weeks of gestational age. Birth weight was between 1 and 1.5 kg. Echocardiogram was confirmatory in 100% of patients; 15 patients did not have pharmacological closure, 12 had pharmacological closure failure, and 4 had medical contraindication for pharmacological closure (sepsis, renal failure and coagulation disturbances). There was no surgical mortality. In patients who died (five patients), it was after 15 or 20 postoperative days and due to problems unrelated to the surgical procedure
Conclusions: Surgical closure of PDA is feasible to perform in a second-level hospital with minimal complications. This was demonstrated with our results in those patients in whom pharmacological closure failed or was not indicated.


REFERENCES

  1. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006;26(suppl 1):S14-18; discussion S22-23.

  2. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation 2006;114:1873-1882.

  3. Dice JE, Bathia J. Patent ductus arteriosus: an overview. J Pediatr Pharmacol Ther 2007;12:138-146.

  4. Lee HC, Silverman N, Hintz SR. Diagnosis of patent ductus arteriosus by a neonatologist with compact, portable ultrasound machine. J Perinatol 2007;27:291-296.

  5. Hammoud MS, Elsori HA, Hanafi EA, Shalabi AA, Fouda IA, Devarajan LV. Incidence and risk factors associated with the patency of ductus arteriosus in preterm infants with respiratory distress syndrome in Kuwait. Saudi Med J 2003;24:982-985.

  6. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000;106:659-671.

  7. DiMenna L, Laabs C, McCoskey L, Seals A. Management of the neonate with patent ductus arteriosus. J Perinat Neonatal Nurs 2006;20:333-340; quiz 341-342.

  8. Del Moral T, González-Quintero VH, Claure N, Vanbuskirk S, Bancalari E. Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants. J Perinatol 2007;27:154-157.

  9. Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995;127:774-779.

  10. Evans N MG, Osborn D, Kluckow M. Diagnosis of patent ductus arteriosus in preterm infants. Neoreviews 2004;45:86-97.

  11. Laughon MM, Simmons MA, Bose CL. Patency of ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr 2004;16:146-151.

  12. Van Overmeier B, Smets K, Lecoutere D, Van de Brock H, Weyler J, Degroote K, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000;343:674-681.

  13. Golombeck SG, Sola A., Baquero H, Borbonet D, Cabañas F, Fajardo C, et al. Primer consenso clínico de SIBEN: enfoque diagnóstico y terapéutico del ductos arterioso permeable en recién nacidos pretérmino. An Pediatr (Barc) 2008;69:454-481.

  14. Gimeno-Navarro A, Modesto-Alapont V, Morcillo-Sopena F, Fernandez-Gilino C, Izquierdo-Macian I, Gutierrez-Laso A. Ibuprofen vs indomethacin in the preterm persistent patent ductus arteriosus therapy: review and meta-analysis. An Pediatr (Barc) 2007;67:309-318.

  15. Carboni MP, Ringel RE. Ductus arteriosus in premature infants beyond the second week of life. Pediatr Cardiol 1997;18:372-375.

  16. Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. J Pediatr 2007;15:229-234.

  17. Koehene PS, Bein G, Alexi-Meskhishvili V, Ewng Y, Burher C, Obladen M. Patent ductus arteriosus in very low birth weight infants: complications of pharmacological and surgical treatment. Perinat Med 2001;29:327-334.

  18. Merrit TA, DiSessa TG, Feldman BH, Kirkpatrick SE, Gluck L, Friedman WF. Closure of patent ductus arteriosus with ligation and indomethacin: a consecutive experience. J Pediatr 1978;93:639-646.

  19. Coster DD, Gorton ME, Grooters RK, Thieman KC, Schneider Rf, Soltanzadeh H. Surgical closure of the patent ductus arteriosus in the neonatal intensive care unit. Ann Thorac Surg 1989;48:386-389.

  20. Davis JT, Baciewicz FA, Suriyapa S, Vauthy P, Polamreddy R, Barnett B. Vocal cord paralysis in premature infants undergoing ductal closure. Ann Thorac Surg 1988;46:214-215.

  21. Mosalli R, Alfaleh K. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev 2008;1:CD006181.

  22. Cassady CD, Kirklin JW. A randomized controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 1989;320:1511-1516.

  23. Moin F, Kennedy KA, Moya FR. Risk factors predicting vasopressor use after patent ductus arteriosus ligation. Am J Perinatol 2003;20:313-320.

  24. Zbar RI, Chen AH, Behrendt DM, Bell EF, Smith RJ. Incidence of vocal fold paralysis in infants undergoing ligation of patent ductus arteriosus. Ann Thorac Surg 1996;61:814-816.




2020     |     www.medigraphic.com